The Bone Morphogenesis Protein-2 (BMP-2) is Associated with Progression to Metastatic Disease in Gastric Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Bone Morphogenetic Proteins (BMPs) are members of the TGF-β superfamily and it has been demonstrated that BMPs enhance migration, invasion and metastasis. The purpose of this study was to identify

the association between the serum BMP-2 level and the progression status of gastric cancer.

Materials and Methods: Fifty-five patients with metastatic gastric cancer (metastatic disease group), six patients with early gastric cancer without lymph node metastasis (the EGC group), and ten healthy control subjects were enrolled in this study. The serum BMP-2 level was quantified by use of a commercially available ELISA kit. In EGC group patients and patients with metastatic disease, whole blood was obtained before endoscopic mucosal resection and before the commencement of a scheduled cycle of systemic chemotherapy, respectively.

Results: No significant difference in the mean serum BMP-2 levels was observed between the control subjects and the EGC group patients (87.95 pg/ml for the control subjects and 84.50 pg/ml for the EGC group, p=1.0). However, the metastatic disease group patients had a significantly higher level of serum BMP (179.61 pg/ml) than the control subjects and EGC group patients (87.95 pg/ml for the control subjects and 84.50 pg/ml for the EGC group, p＜0.0001). Moreover, the mean serum BMP-2 level from patients with a bone metastasis was significantly higher than the mean serum BMP-2 level from patients without a bone metastasis (204.73 pg/ml versus 173.33 pg/ml, p=0.021).

Conclusions: BMP-2 seems to have a role in progression to metastatic disease in gastric cancer, especially in the late stage of tumorigenesis, including invasion and metastasis. BMP-2 may facilitate bone metastasis in gastric cancer. To confirm these findings, further studies are required with tissue specimens and the use of a cancer cell line.

참고문헌 (Reference)

• 1 Langenfeld EM, "The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells" 24 : 1445-54, 2003
• 2 Cao X., "The BMP signaling and in vivo bone formation" 357 : 1-8, 2005
• 3 Yoo YA, "Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway" 29 : 480-90, 2008
• 4 Kim IY, "Role of bone morphogenetic proteins in transitional cell carcinoma cells" 241 : 118-23, 2006
• 5 Raida M., "Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells" 18 : 735-9, 2006
• 6 Sampath TK, "Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro" 267 : 20352-62, 1992
• 7 Feeley BT, "Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions" 38 : 154-66, 2006
• 8 Masuda H., "Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer" 54 : 268-74, 2003
• 9 Arnold SF, "Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2" 11 : 1031-7, 1999
• 10 Yang S., "Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells" 65 : 5769-77, 2005
• 11 Kim IY, "Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells" 9 : 6046-51, 2003
• 12 Rothhammer T., "Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration" 65 : 448-56, 2005
• 13 Hogan BL, "Bone morphogenetic proteins: multifunctional regulators of vertebrate development" 10 : 1580-94, 1996
• 14 Piccirillo SG, "Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells" 444 : 761-5, 2006
• 15 Deng H., "Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells" 313 : 1033-44, 2007
• 16 Montesano R., "Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth" 353 : 817-22, 2007
• 17 Langenfeld EM, "Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5" 25 : 685-92, 2006
• 18 Hardwick JC, "Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon" 126 : 111-21, 2004
• 19 Kleeff J., "Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo" 116 : 1202-16, 1999
• 20 Clement JH, "Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells" 27 : 401-7, 2005
• 21 Kawamura C., "Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells" 43 : 635-9, 2002
• 22 Ma L., "Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning" 132 : 5601-11, 2005
• 23 Theriault BL, "BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells" 28 : 1153-62, 2007
• 24 Wen XZ, "BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells" 316 : 100-6, 2004
• 25 Hallahan AR, "BMP-2 mediates retinoidinduced apoptosis in medulloblastoma cells through a paracrine effect" 9 : 1033-8, 2003